Title
Category
Credits
Event date
Cost
Interprofessional Education and Interprofessional Practice
  • AUHCOP Preceptor Resources
  • 2.00 ACPE Pharmacy
$0.00
This course is an orientation for AUHCOP Preceptors. This program has been approved by the Alabama Board of Pharmacy for continuing education credit to meet Preceptor licensure requirements. An access code for this course will be provided by the Experiential Programs Office.  
The Art of Experiential Learning
  • AUHCOP Preceptor Resources
  • 1.00 ACPE Pharmacy
$0.00
This course is an orientation for AUHCOP Preceptors. The presentation discusses the four roles of preceptors and quality feedback for learners. This is a preceptor development topic that can be used by all preceptors. An access code for this course will be provided by the Experiential Programs Office. This program has been approved by the Alabama Board of Pharmacy for continuing education credit to meet Preceptor licensure requirements. 
Recorded 2024 LIVE @ LUNCH - OTC Update: Combatting Cough & Cold Symptoms
  • Live @ Lunch
  • 1.00 ACPE Pharmacy
$25.00
LIVE @ LUNCH - OTC Update: Combatting Cough & Cold Symptoms webinar is part of our LIVE @ LUNCH Webinar Subscription. There are five 1-hour courses included in this webinar series and each can be purchased separately for $25 each. If you are interested in signing up for the $100 webinar subscription for all 5 LIVE @ LUNCH programs, you may do so by clicking on the following link below and will receive a code to register for all 2024 Live @ Lunch webinars.
Recorded Sterile Compounding Review for ALBOP Recertification 2024
  • Sterile Compounding Certification
  • 2.00 ACPE Pharmacy
  • 2.00 ACPE Technician
$50.00
This 2-hour CE is on the topic of sterile compounding of nonhazardous and hazardous drugs and aims to fulfill the requirements for the Alabama State Board of Pharmacy for recertification for pharmacists involved in parenteral compounding.
Recorded 2024 LIVE @ LUNCH - New Drug Update 2024
  • Live @ Lunch
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
$25.00
LIVE @ LUNCH - New Drug Update 2024 webinar is part of our LIVE @ LUNCH Webinar Subscription. There are five 1-hour courses included in this webinar series and each can be purchased separately for $25 each. If you are interested in signing up for the $100 webinar subscription for all 5 LIVE @ LUNCH programs, you may do so by clicking on the following link below and will receive a code to register for all 2024 Live @ Lunch webinars.
Treatment of Clostridioides difficile Infection
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This program will describe the risk factors associated with C. difficile infection (CID) and will focus on the current recommended treatment options, both pharmacotherapy and non-pharmacotherapy.  Additionally, the program will discuss new options that have recently come to the market for the treatment and prevention of CDI.
The Treatment of Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP)
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This is part of the CE programming on Improving Antimicrobial Stewardship Across Alabama (IASAA). Specifically this CE will evaluate the treatment of HAP and VAP.This program is sponsored through a grant from the Alabama Department of Public Health, Bureau of Communicable Disease Infectious Diseases and Outbreaks through a Cooperative Agreement with the Centers for Disease Control and Prevention, grant number 6 NU50CK000545-03-02, Strengthening HAI/AR (SHARP) CFDA 93.323.
Sepsis Stewardship: Treatment of Sepsis and Septic Shock
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will discuss the treatment of sepsis and septic shock. It will discuss how to prioritize treatment choices, practical logistic needs and applications, and how to de-escalate therapy as the patient recovers.This program is sponsored through a grant from the Alabama Department of Public Health, Bureau of Communicable Disease Infectious Diseases and Outbreaks through a Cooperative Agreement with the Centers for Disease Control and Prevention, grant number 6 NU50CK000545-03-02, Strengthening HAI/AR (SHARP) CFDA 93.323.
Recorded Treatment of Skin and Soft Tissue Infections (SSTIs), Diabetes-related Foot Infections (DFIs) and Osteomyelitis
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.80 ABN
  • 1.50 ACPE Pharmacy
  • 1.50 AMA PRA Category 1 Credit™
$0.00
Skin and soft tissues infections, diabetes-related foot infections, and osteomyelitis are frequently occurring infections among patients in both the inpatient and outpatient settings. Appropriate classification of these infections and recognition of the corresponding common causative pathogen are essential to determine optimal empiric antimicrobial therapy. This presentation will review types of SSTI and osteomyelitis along with common pathogens and discuss aspects of antimicrobial therapy for treatment of SSTI and osteomyelitis, including dosing, route, monitoring parameters and duration.
Recorded Treatment of Urinary Tract Infections
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.80 ABN
  • 1.50 ACPE Pharmacy
  • 1.50 AMA PRA Category 1 Credit™
$0.00
Urinary tract infections (UTIs) are one of the most common indications for receipt of antimicrobial therapy in both the community, hospital, and long-term care settings.  However, inappropriate use of broad-spectrum antibiotics for the treatment of UTIs has significantly contributed to the development of antimicrobial resistance to UTI pathogens.

Pages